Table 2.
Aims of research and appropriate biomarkers
| Aim: | Suitable marker |
|---|---|
| Monitoring general kidney function (GFR) | CysC |
| Differentiate between glomerular and tubular damage | KIM-1, clusterin, αGST |
| Monitor toxicity with suspected glomerular localization | B2M |
| Monitor toxicity with suspected non-glomerular localization | CysC, NGAL, |
| Detect early kidney injury with suspected proximal tubular localization | αGST, KIM-1 |
| Monitor reversibility/regeneration with suspected proximal tubular localization | KIM-1 |
| Monitor toxicity with suspected distal tubular localization | Clusterin |
| Monitor reversibility/regeneration with suspected distal tubular localization | Clusterin |
| Elucidate pathophysiological mechanism with known proximal tubular injury site | NAG |
| High risk of acute tubular necrosis (Phase II/III trials) | IL18 |